What is the debt of Amedisys this year?
Amedisys has a debt level of 271.73 USD this year.
Amedisys Debt 2024
Amedisys Debt
271.73 USD
Amedisys Dividend yield
Ticker
AMED
ISIN
US0234361089
WKN
915582
In 2024, Amedisys's total debt was 271.73 USD, a -31.1% change from the 394.4 USD total debt recorded in the previous year.
Amedisys Aktienanalyse
What does Amedisys do?
Amedisys Inc is a US home healthcare provider that offers a variety of healthcare services in the private home, including home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. The company was founded in 1982 by William F. Borne and Michael J. Borne and is headquartered in Baton Rouge, Louisiana. History In the 1980s, while William and Michael Borne were running a nursing home together, they recognized a demand for home healthcare and founded Amedisys in 1982. The company started with a small group of nurses making house calls and was based on the belief that people would prefer to be cared for at home rather than being placed in a facility. In 1999, Amedisys was acquired by the American Stock Exchange and was able to steadily improve its performance and expand its business model to multiple states. In 2007, the company went public and has been listed on NASDAQ since. Business Model Amedisys offers a wide range of healthcare services that are typically received by patients at home. The services include home nursing, palliative care, physical therapy and rehabilitation, infusion therapy, and psychiatric care. Amedisys collaborates with over 360 medical faculties and over 7,500 medical professionals who provide healthcare to over 385,000 patients per year. Amedisys also offers training programs for nurses and other employees to discover the business and potential growth opportunities. The company relies on teamwork to motivate staff and keep their knowledge and skills up-to-date. Segments Amedisys operates in two main business segments: home healthcare and hospice care. Both segments offer specialized services and are provided by professionals such as registered nurses, therapists, medical assistants, and social workers. The company has more than 435 hospice facilities in 34 US states and over 197 home healthcare branches in 38 US states. Products Amedisys offers a variety of products, including infusion therapy, professional wound management, clinical respiratory therapy, polypharmacy management, specialized care services, and palliative care. The company also provides telemedicine options for patients to receive care from home. Summary Amedisys is a leading provider of home healthcare and hospice care in the US. The company offers a wide range of services and is able to serve both the inpatient and outpatient settings. The company relies on teamwork to provide comprehensive and high-quality care to patients. Amedisys is a successful and expanding company that is also exploring new market potentials through the use of technology. Amedisys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Amedisys's Debt Structure
Amedisys's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Amedisys's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Amedisys’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Amedisys’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Amedisys Stock
What was the debt of Amedisys compared to the previous year?
The debt of Amedisys has increased by -31.1% compared to the previous year dropped.
What are the consequences of high debt for investors in Amedisys?
High debt can pose a risk for investors of Amedisys, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Amedisys?
Low debt means that Amedisys has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Amedisys affect the company?
An increase in debt of Amedisys can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Amedisys affect the company?
A reduction in debt of Amedisys can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Amedisys?
Some factors that can influence the debt of Amedisys include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Amedisys so important for investors?
The debts of Amedisys are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Amedisys take to change the debt?
To change the debt, Amedisys can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Amedisys pay?
Over the past 12 months, Amedisys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amedisys is expected to pay a dividend of 0 USD.
What is the dividend yield of Amedisys?
The current dividend yield of Amedisys is .
When does Amedisys pay dividends?
Amedisys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Amedisys?
Amedisys paid dividends every year for the past 0 years.
What is the dividend of Amedisys?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Amedisys located?
Amedisys is assigned to the 'Health' sector.
Wann musste ich die Aktien von Amedisys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Amedisys from 5/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.
When did Amedisys pay the last dividend?
The last dividend was paid out on 5/28/2024.
What was the dividend of Amedisys in the year 2023?
In the year 2023, Amedisys distributed 0 USD as dividends.
In which currency does Amedisys pay out the dividend?
The dividends of Amedisys are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Amedisys stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Amedisys
Our stock analysis for Amedisys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amedisys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
